Catalyst Wire Dossier Catalyst Wire Dossier

Olmesartan Medoxomil and Hydrochlorothiazide

olmesartan medoxomil; hydrochlorothiazide · Ascend Laboratories, LLC
Drug timelines are a Plus or Pro feature.

18 regulatory and trial events tracked for Olmesartan Medoxomil and Hydrochlorothiazide, covering 2017-04-24 to 2026-04-23. Get the full timeline:

Most recent: FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Ascend Laboratories, LLC)

See pricing